1. Home
  2. VIR vs BFS Comparison

VIR vs BFS Comparison

Compare VIR & BFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$5.97

Market Cap

825.0M

Sector

Health Care

ML Signal

HOLD

BFS

Saul Centers Inc.

HOLD

Current Price

$32.47

Market Cap

770.9M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIR
BFS
Founded
2016
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
825.0M
770.9M
IPO Year
2019
1993

Fundamental Metrics

Financial Performance
Metric
VIR
BFS
Price
$5.97
$32.47
Analyst Decision
Strong Buy
Analyst Count
11
0
Target Price
$25.73
N/A
AVG Volume (30 Days)
1.8M
80.5K
Earning Date
02-25-2026
02-27-2026
Dividend Yield
N/A
7.35%
EPS Growth
N/A
N/A
EPS
N/A
1.14
Revenue
$16,860,000.00
$282,618,000.00
Revenue This Year
N/A
$8.14
Revenue Next Year
$46.25
$5.75
P/E Ratio
N/A
$28.16
Revenue Growth
N/A
5.61
52 Week Low
$4.16
$29.16
52 Week High
$14.45
$38.43

Technical Indicators

Market Signals
Indicator
VIR
BFS
Relative Strength Index (RSI) 48.75 66.72
Support Level $5.55 $30.81
Resistance Level $6.30 $31.82
Average True Range (ATR) 0.30 0.51
MACD -0.02 0.05
Stochastic Oscillator 57.05 88.60

Price Performance

Historical Comparison
VIR
BFS

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About BFS Saul Centers Inc.

Saul Centers Inc is a self-managed real estate investment trust which invests in, operates and develops retail and commercial properties. The company's portfolio includes community and neighbourhood shopping centres, office properties, and mixed-use properties. Properties are located in the Washington, D.C. and Batlimore metropolitan areas. Saul Centers operates through two business segments: shopping centers, which contribute the maximum portion of total revenue; and mixed-use properties. Maximum tenants include grocery stores, discount department stores, and drug stores.

Share on Social Networks: